In-depth Research Report on the Pathophysiological Nature, Multimodal Treatment Strategies, and Vaccine Intervention Effects of Feline Chronic Gingivostomatitis

Disease Definition and Epidemiological Scope of Feline Chronic Gingivostomatitis (FCGS)

Feline Chronic Gingivostomatitis (FCGS) is an extremely challenging chronic inflammatory disease in feline clinical medicine, characterized by severe, diffuse ulcerative or proliferative inflammation of the oral mucosa ¹. This pathological state is fundamentally different from ordinary gingivitis or periodontal disease, mainly manifested by the inflammatory response crossing the mucogingival junction and extending to the alveolar mucosa, buccal mucosa, sublingual tissue, and most critically, the caudal oral mucosa (lateral aspect of the palatoglossal arch) ³.

From an epidemiological perspective, the prevalence of FCGS in the general feline population is estimated to be between 0.7% and 12%, but this proportion may be higher in sick cats under veterinary observation ¹. The disease affects all breeds, genders, and ages, although studies have shown that certain purebred cats such as Maine Coons and Siamese cats may have a higher susceptibility ⁶. The onset of FCGS is closely related to the teething period, multi-cat environments, and the individual's immune status ⁸. Affected cats often suffer from extreme oral pain, presenting with salivation, difficulty eating, weight loss, unkempt fur, and personality changes due to pain, such as hiding or irritability ³.

Due to its long course, high recurrence rate, and limited response to traditional drug therapy, FCGS is regarded as one of the major obstacles to improving feline welfare ². In extreme cases, some owners opt for euthanasia due to high treatment costs or the extremely poor quality of life of the affected cats ¹.

Epidemiological Parameters	Statistical Data and Characteristics	Source of Evidence
Population Prevalence	0.7% - 12% (general feline population); up to 26% (domestic cat population)	¹
Typical Age of Onset	Any stage after teething, with a median age of onset of approximately 72 months	⁶
Predisposed Breeds	Purebred cats such as Maine Coon, Siamese, and Abyssinian show higher incidence rates	⁴
Main Clinical Signs	Severe oral pain, halitosis, salivation (often blood-tinged), dysphagia, refusal to eat	³
Histological Characteristics	Lymphoplasmacytic infiltration, accompanied by a large number of plasma cells, T cells, and Mott cells	¹

Pathophysiological Nature of FCGS: Immune Dysregulation and T-Cell Exhaustion

The underlying cause of FCGS is not a single pathogen infection but a complex, multifactorial-induced immune-mediated disease ². Its core pathological mechanism lies in the dysregulation of the local mucosal immune system or loss of immune tolerance in the cat's oral cavity, leading to an excessive inflammatory response of the body to normal flora or viral antigens in the oral cavity ¹.

Alterations in T-Cell Subsets and Systemic Activation

In the pathophysiological process of FCGS, T lymphocytes, especially CD8+ cytotoxic T cells, play a decisive role ¹. Studies have found extremely dense lymphoplasmacytic infiltration in the oral lesion tissues of affected cats ¹. Flow cytometric analysis of blood samples from affected cats reveals systemic immune activation:

Imbalanced CD4/CD8 Ratio: The proportion of CD8+ T cells in the blood of affected cats is significantly increased, resulting in a significant decrease in the ![][image1] ratio ¹.
Expansion of Effector Memory Cells: Most CD8+ cells exhibit an effector memory phenotype (CD8+CD45-CD62L-), indicating that the immune system is in a state of long-term, exhausted activation ¹.
T-Cell Exhaustion: Long-term antigen stimulation leads to functional exhaustion of T cells, making them unable to effectively eliminate pathogens but instead causing tissue damage through the continuous release of inflammatory mediators ³.
Impaired Regulatory T-Cell (Treg) Function: Although FOXP3+ Treg cells are present in lesion tissues, they cannot effectively suppress pro-inflammatory responses, resulting in an unremitting inflammatory cascade ¹.

Cytokine Storm and Molecular Signaling Pathways

The chronic inflammation of FCGS is driven by a series of pro-inflammatory cytokines. Levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly upregulated in both local mucosa and systemic circulation ¹. In addition, local mRNA expression analysis shows significant changes in the levels of factors such as IL-2, IL-4, IL-10, and IL-12 ³.

The persistent presence of these cytokines triggers the following biological effects:

Tissue Remodeling: Cytokines induce basal cell degeneration and basement membrane disruption, promoting lymphocyte migration into the epidermis ¹.
Plasma Cell Differentiation: Factors such as IL-6 promote the transformation of B cells into plasma cells, producing a large number of non-specific antibodies, leading to hypergammaglobulinemia ¹.
Pain Mechanism: Inflammatory mediators directly stimulate oral nerve endings and cause local tissue edema and ulceration, resulting in the extreme pain observed clinically ³.

Translational Medical Links Between FCGS and Human Oral Lichen Planus (OLP)

Growing evidence indicates that FCGS shares striking similarities with human Oral Lichen Planus (OLP) in clinical manifestations, histopathology, and immunological characteristics ¹. Both are centered on chronic, immune-mediated oral mucosal inflammation, and their histological features are characterized by dense lymphoplasmacytic infiltration and degenerative changes in subepithelial basal cells ¹. This similarity makes FCGS an extremely relevant natural animal model for studying human autoimmune diseases of the oral mucosa ¹.

Multifactorial Etiological Analysis: Interplay of Viruses, Bacteria, and Environment

Although the pathological basis of FCGS is immune dysregulation, the "antigenic stimulants" that trigger this abnormal immune response are usually multifaceted ⁸.

Driving Role of Viral Factors

Feline Calicivirus (FCV) is considered the most important viral cofactor for FCGS ³.

High Detection Rate of FCV: The detection rate of FCV in FCGS-affected cats is usually between 70% and 90%, compared with only about 20% in healthy cat populations ⁸.
Pathogenic Mechanism: FCV may damage the integrity of oral epithelial cells, making it easier for other antigens (such as bacterial toxins) to penetrate into deep tissues, thereby triggering an excessive immune response ⁸. Experiments have shown that inoculation with specific FCV strains can induce acute caudal mucosal inflammation in experimental cats ¹⁵.
Synergistic Effect of Other Viruses: Feline Herpesvirus-1 (FHV-1), feline retroviruses (FIV and FeLV), and recently mentioned Feline Foamy Virus (FFV) are also associated with the occurrence or treatment resistance of FCGS ². In particular, FeLV-positive cats have a significantly reduced likelihood of postoperative recovery, with a 7.5-fold increased risk ⁴.

Dysbiosis of the Oral Microbiome

Disruption of the balance of the oral microbial community is another key point in the progression of FCGS. The bacterial diversity in the oral cavity of affected cats is usually increased, and the microbial composition shows a significant shift ⁹.

Overgrowth of Anaerobes: The detection rate of anaerobes in the oral cavity of FCGS cats is significantly higher than that in healthy cats. The main pathogenic candidate flora include Porphyromonas, Treponema, and Fusobacterium ⁹.
Role of Pasteurella: Pasteurella multocida can be isolated in about half of the cases, and it may act as a secondary infection source to exacerbate inflammation ⁸.
Dental Plaque Intolerance: FCGS-affected cats are thought to have a "hypersensitivity reaction" to extremely small amounts of dental plaque antigens, and this intolerance drives the chronicity of inflammation ⁸.

Environmental and Host Risk Factors

Multi-cat Environment and Stress: Multi-cat living environments not only increase the transmission probability of viruses (such as FCV) but also affect the immune system balance of cats through social stress ⁵.
Stray History: Cats with a stray history are more likely to develop FCGS, which may be related to early pathogen exposure, malnutrition, and antigen load during immune system development ⁹.
Dental Comorbidities: Tooth resorption (TR) and periodontitis are extremely common in FCGS cats. The ecological niches provided by these lesions are conducive to the growth of pathogenic bacteria, further stimulating the impaired immune system ⁵.

Clinical Diagnosis and Severity Assessment

Since FCGS is a diagnosis of exclusion, clinicians must combine medical history, clinical signs, laboratory tests, and possible histopathology to confirm the diagnosis ⁵.

Clinical Classification: Type 1 vs Type 2

Current veterinary clinical research classifies FCGS into two main clinical phenotypes, which are crucial for prognosis judgment ⁴:

Type 1 FCGS: Inflammation mainly involves the alveolar mucosa and buccal mucosa, usually in areas where teeth are present. Such cases usually respond well to treatment, with higher surgical cure rates.
Type 2 FCGS: Inflammation significantly involves the caudal oral mucosa (pharyngeal region, lateral aspect of the palatoglossal arch). This is the most severe form of the disease, with a generally poor prognosis and a higher tendency to develop into refractory cases.

Stomatitis Disease Activity Index (SDAI) Scoring System

To objectively measure the disease condition and track treatment effects, veterinary dentistry experts usually adopt the "Stomatitis Disease Activity Index (SDAI)" scoring system developed by Dr. Jamie Anderson ². This system integrates subjective assessment (owner feedback) and objective evaluation (clinical examination):

SDAI Assessment Dimensions	Scoring Criteria (0-3)	Clinical Manifestations
Owner Assessment: Appetite/Comfort	0: Normal; 3: Extremely poor	Whether the cat refuses to eat or shows obvious oral pain behaviors
Owner Assessment: Grooming Behavior	0: Normal; 3: No grooming	Whether the fur is matted, messy, and whether there is secretion residue in the oral cavity
Oral Examination: Caudal Mucosa	0: Normal; 3: Severe ulceration/proliferation	Extent and depth of inflammation in the palatoglossal arch area
Oral Examination: Buccal Mucosa	0: Normal; 3: Severe inflammation	Degree of redness and swelling of the buccal inner wall corresponding to the teeth
Oral Examination: Sublingual Tissue	0: Normal; 3: Significant edema/ulceration	Involvement of the sublingual frenulum and surrounding tissues
Inflammatory Index: Spontaneous Bleeding	0: None; 3: Massive bleeding upon touch or spontaneously	Reflects the high fragility and inflammatory intensity of mucosal blood vessels

Surgical Intervention: Logic and Actual Effects of Full-Mouth Extraction

In current treatment guidelines, extraction of some or all teeth is considered the first-choice and most effective treatment option for FCGS ⁴.

Scientific Basis for Surgical Treatment

Tooth extraction is not to "solve tooth problems" but to remove antigen carriers. Since the essence of FCGS is an excessive immune response to bacteria (dental plaque) attached to the tooth surface, removing the teeth can completely eliminate the physical structures to which these antigens attach, thereby breaking the inflammatory cycle ⁸.

Extraction Strategies: PME vs FME

Partial Mouth Extraction (PME): Usually includes extraction of all premolars and molars. If the tissues around the canines and incisors are not inflamed, they can be retained ⁶.
Full-Mouth Extraction (FME): In cases where the entire oral tissues are involved, or inflammation does not improve after PME, full-mouth extraction must be performed ²².
Success Rate Statistics: Approximately 70% to 80% of affected cats achieve substantial clinical improvement or complete cure after tooth extraction surgery ⁴.
Key Technical Points: Postoperative X-rays must be taken during surgery to ensure that no root fragments are left behind. Any residual tiny roots will cause the immune system to continue attacking, rendering the surgery futile ⁵.

Quality of Life Assessment After Surgery

Owners are usually concerned that cats cannot live normally after losing their teeth. However, clinical evidence shows that the quality of life of most cats improves dramatically after postoperative pain elimination ²⁷. Once the affected tissues heal, cats can not only eat wet food but also normally ingest dry food ²⁷. Facial swelling and bloody saliva within 72 hours after surgery are normal, and with modern multimodal analgesic management, cats can usually resume eating within a few hours after surgery ²⁴.

Medication Management: Perioperative Adjuvant Therapy and Control of Refractory Cases

Although surgery is the cornerstone, approximately 20-30% of cases are refractory FCGS and require long-term medication assistance ⁴.

Traditional Anti-Inflammatory and Immunosuppressive Therapy

Corticosteroids (e.g., Prednisolone): Mainly used for short-term relief of extremely severe inflammation and pain. Although effective, long-term use can lead to resistance and may cause side effects such as diabetes, iatrogenic Cushing's syndrome, and skin fragility ⁵.
Cyclosporine: A calcineurin inhibitor that can effectively inhibit T-cell activation. Studies have shown that approximately 50% of cats with residual inflammation after tooth extraction achieve significant remission after 3-6 months of cyclosporine treatment ⁵.
Antibiotic Therapy: Amoxicillin-clavulanate or clindamycin are often selected, mainly to reduce the oral bacterial load, improve tissue fragility, and create conditions for surgery or healing ⁵.

Immunomodulatory and Antiviral Agents

Recombinant Feline Interferon-ω (rFeIFN-ω): As an antiviral and immunomodulatory agent, interferon has shown certain efficacy in FCV-positive FCGS cats ⁴. Mucosal administration (oral spray) can induce the production of antiviral proteins locally and regulate the local immune microenvironment ³⁶.
Pain Management (Analgesics): Due to the extreme pain caused by FCGS, neuropathic pain medications (such as gabapentin) and long-acting analgesics (such as buprenorphine) are indispensable components of treatment ²⁴.

Cutting-Edge Therapy: Immune Remodeling with Mesenchymal Stem Cells (MSC)

For those extremely severe refractory cases that still fail to heal after tooth extraction surgery, mesenchymal stem cell therapy (MSC) offers unprecedented hope ².

Therapeutic Mechanism of MSC

Mesenchymal stem cells are not simply "repair cells"; they are more like "dispatchers of the immune system". Through intravenous infusion, MSCs can migrate to the damaged oral mucosa and, by releasing paracrine factors (such as PGE2, IDO, and TGF-β) ³:

Downregulate the proportion of activated CD8+ T cells.
Restore the function of impaired Treg cells.
Inhibit excessive activation of neutrophils and plasma cells.
Remodel the damaged epithelial barrier.

Clinical Trial Data and Safety

In a series of clinical studies at the University of California, Davis (UC Davis), researchers administered two MSC injections (20 million cells each, 30 days apart) to affected cats that were unresponsive to tooth extraction ⁴:

Success Rate: The overall response rate reached 65.5% to 72% ⁴.
Long-Term Effects: Approximately 58.6% of cats achieved permanent cure or long-term remission without medication ²¹.
Cell Source: Autologous adipose-derived stem cells (Autologous adMSC) have better long-term stability than allogeneic cells and avoid the risk of allogeneic immune reactions ²¹.
Stem Cell Secretome: The latest case studies show that the use of human-derived MSC secretome may also have certain anti-inflammatory potential, although the sample size is currently extremely small ¹⁴.

MSC Therapy Indicators	Research Conclusions (UC Davis and Multicenter Studies)	Source of Evidence
Administration Route	Intravenous injection (IV)	⁴
Recommended Regimen	20 million cells/time, 2 times in total, 3-4 weeks apart	⁴
Overall Response Rate	Approximately 70%	⁴
Complete Remission Rate	Approximately 60%	²¹
Common Side Effects	Transient infusion reactions (e.g., fever, chills), mostly self-limiting	²¹
Optimal Intervention Timing	Within 6 months after tooth extraction surgery (significantly higher cure rate)	¹⁰

Molnupiravir: A New Weapon for FCV-Associated Stomatitis

In studying the causal link between viruses and FCGS, past research has been limited due to the lack of effective antiviral drugs. However, the emergence of the nucleoside analog Molnupiravir (MPV) has changed this situation ³².

Effect of MPV on Feline Calicivirus

Molnupiravir was originally used for the treatment of human COVID-19 and feline infectious peritonitis (FIP). It is a broad-spectrum antiviral prodrug that induces lethal mutations in RNA polymerase during viral replication ³².

Direct Antiviral Effect: In preliminary clinical pilot studies, treatment of FCV-positive FCGS cats with MPV significantly reduced viral shedding and promoted mucosal healing ³².
Clinical Cases: Some cases showed negative FCV tests and resolution of previously refractory oral inflammation after continuous treatment with MPV (10-20 mg/kg, BID) for 1-2 months ³².

Molnupiravir Triple Combination Ointment

The latest clinical practice has proposed a "triple combination" local/systemic regimen targeting the multifactorial nature of FCGS ³⁸:

Molnupiravir (85 mg/mL): Targets FCV replication.
Doxycycline (25 mg/mL): Controls microbial dysbiosis and exerts immunomodulatory effects.
Meloxicam (0.0625 mg/mL): Provides continuous analgesia and anti-inflammatory effects within a safe range. This regimen has shown excellent compliance and clinical effects in preliminary pilot trials, with affected cats usually resuming normal eating within 2-3 months ³⁸.

Physical Adjuvant Therapy: Low-Level Laser Therapy (LLLT) and Laser Ablation

In addition to surgery and medication, physical therapy methods play a role in pain management and tissue smoothing in FCGS.

Photobiomodulation Therapy (PBM/LLLT)

Low-level laser (600-1100 nm) can promote cell metabolism, reduce inflammation, and accelerate healing by stimulating cytochrome c oxidase in mitochondria ⁴¹.

Advantages of Extraoral Application: Since FCGS cats usually resist opening their mouths, the "extraoral technique" of irradiation through the skin outside the cheek has been proven to have good energy penetration ability and can effectively cover the damaged mucosa inside ³⁴.
Pain Relief: Clinical observations show that regular laser physical therapy can significantly reduce the SDAI score and improve the comfort of affected cats ⁴³.

Laser Tissue Ablation

For the proliferative granulation tissue in the pharynx common in Type 2 FCGS, laser is used for surgical resection ²⁵.

Surgical Advantages: The wavelength of laser is easily absorbed by water, and it has excellent coagulation and bactericidal effects while resecting tissue ²⁵.
Operation Modes: Resection with high power (e.g., 10 W continuous wave), or "rasterization" after local carbonization with low power, can significantly reduce the volume of lesion tissue ²⁵.

Complex Effects of Vaccines on FCGS: From Protection to Challenges

The impact of vaccines on FCGS is one of the core contradictions in research. The key point is: how to balance the protective effect of vaccines in preventing viruses (such as FCV) and the excessive immune response that vaccines may induce.

Protective Effects from an Epidemiological Perspective

Despite controversies, most studies support that appropriate immunization can reduce the risk of FCGS onset ⁹.

Immune Status Correlation: Statistics on a large number of FCGS cats show that unvaccinated or incompletely vaccinated cats account for up to 80% of the total number of cases ⁹. This indicates that infection with core pathogens such as FCV is the trigger for immune dysregulation.
Herd Immunity: WSAVA recommends achieving "herd immunity" through high vaccination rates, thereby reducing the prevalence of virulent strains (such as VS-FCV) in the environment and indirectly protecting susceptible cats ⁴⁵.

Negative Observations Related to Vaccines

Paradox Effect: Clinical observations have pointed out that some kittens may develop transient oral inflammation shortly after receiving FCV vaccines (especially modified live vaccines, MLV) ⁸. It is currently unclear whether this is a hypersensitivity reaction caused by vaccine components or local replication of the vaccine strain itself in individuals.
Inability to Provide 100% Protection: Due to the high variability of FCV, current vaccine strains (mainly F9 strain-related) cannot provide complete cross-protection against all variant strains that may cause FCGS ⁴⁷. Therefore, even vaccinated cats may still develop FCGS when exposed to highly virulent strains ⁹.

WSAVA and ISFM Vaccination Guidelines for Affected Cats

For cats already suffering from or with a history of FCGS, international authoritative organizations (WSAVA/ISFM) have given detailed recommendations ⁴⁹:

Vaccine Necessity: Even if a cat has been infected with FCV and has stomatitis, vaccination is still recommended. Because antibodies produced by natural infection cannot defend against all strains, and vaccines can reduce the severity after future exposure ⁴⁷.
Inactivated Vaccines Are Preferred Over Live Vaccines: For FCGS cats with immune dysregulation or retroviral infections (FIV/FeLV), inactivated vaccines are recommended as the first choice to eliminate the possibility of accidental symptoms caused by attenuated strains in individuals ⁵⁰.
Selection of Vaccination Timing: Vaccination should be performed during the stable phase of the disease (e.g., the stage when inflammation subsides after tooth extraction surgery). Vaccination during the acute, severe inflammatory phase may lead to further disorders of the immune system.
Risk Assessment and Individualization: For fully indoor single-cat households, if environmental risks are excluded, the vaccination interval can be extended (e.g., once every 3 years); while cats in multi-cat environments are recommended to receive booster immunization for core vaccines (especially FCV/FHV-1) every year ⁴⁵.

Vaccine Type and Characteristics	Application Considerations in FCGS Patients	Guideline Recommendations
Modified Live Vaccine (MLV)	Fast onset, but theoretically minimal risk of inducing local inflammation	First choice for healthy cats, use with caution in immunocompromised cats
Inactivated Vaccine (Killed)	Extremely high safety, does not cause viral replication	First choice for FCGS and retrovirus-infected cats
Core Components (FPV, FCV, FHV-1)	Prevent major viral triggers	Basic protection item for FCGS-affected cats
Intranasal Vaccine	Produces local mucosal immunity, extremely fast onset	Emergency response plan in outbreak environments

Comprehensive Management Pathway: From Initial Diagnosis to Long-Term Recovery

The successful treatment of FCGS relies on a rigorous, "progressive" multimodal approach ⁴.

Phase 1: Diagnosis and Stability Establishment

Exclude other oral malignant tumors (biopsy).
Full-mouth X-ray evaluation (to confirm tooth status).
Retrovirus screening (FeLV/FIV).
Administer emergency analgesic and anti-infective treatment to improve the cat's nutritional intake (esophageal feeding tube if necessary) ⁴.

Phase 2: Surgical Decompression

Perform PME or FME (full-mouth extraction).
Emphasize smoothing the alveolar bone surface and removing all residual tissues (including residual periodontal ligaments) ²⁶.
Postoperative multimodal analgesic management (72-hour golden period).

Phase 3: Follow-Up Assessment and Refractory Management

Follow-up visits at 1, 3, and 6 months after surgery to record SDAI scores ².
If there is no significant improvement after tooth extraction (refractory), initiate secondary regimens:
- Stem cell therapy (if economic conditions permit).
- Molnupiravir antiviral course (for cases with persistent FCV positivity).
- Mucosal administration of interferon in the oral cavity.
- Adjuvant low-level laser therapy (LLLT).

Phase 4: Long-Term Maintenance and Lifestyle Optimization

Reduce environmental stress.
Personalized vaccination plan based on risk assessment.
Regular oral examinations to ensure the mucosa remains in a healthy state ⁴.

Conclusions and Outlook

Feline Chronic Gingivostomatitis (FCGS) is essentially a T-cell-mediated immune failure driven by cytotoxic T cells that cannot terminate itself in the oral mucosa of cats, resulting from the combined action of complex viral, bacterial, and environmental factors ¹. Although tooth extraction surgery is still the treatment with the highest cure rate (up to 80%) at present, we must face up to the "refractory" group that does not respond to traditional surgery ⁴.

With the deepening of translational medical research, the treatment of FCGS is undergoing a paradigm shift: from a single "resection"-oriented approach to "immune remodeling" based on stem cells and "antigen eradication" based on novel nucleoside analogs (such as molnupiravir) ¹⁰. The role of vaccines has also changed from being questioned to being scientifically managed—the core goal is to utilize their protective efficacy while minimizing secondary interference to the imbalanced immune system through reasonable selection of vaccination timing and vaccine types ⁹.

Ultimately, the management goal of FCGS is not only to eliminate inflammation but also to restore the pain-free life and normal behavioral expression of affected cats. The future challenge lies in reducing the cost of these cutting-edge therapies (such as MSC) and developing more targeted new drugs that can restore mucosal immune tolerance. For clinicians and owners, early diagnosis, thorough surgical treatment, and scientific postoperative management remain the three cornerstones for changing the fate of affected cats ².

引用的著作

Local and systemic immunological response in feline chronic gingivostomatitis: a critical review - Frontiers, 访问时间为四月 7, 2026， https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1572631/full
Feline Chronic Gingivostomatitis Diagnosis and Treatment through Transcriptomic Insights, 访问时间为四月 7, 2026， https://www.mdpi.com/2076-0817/13/3/192
Feline Chronic Gingivostomatitis (FCGS) - Gallant, 访问时间为四月 7, 2026， https://www.gallant.com/conditions-we-target/feline-chronic-gingivostomatitis/
Feline Chronic Gingivostomatitis (FCGS): Diagnosis, Surgical Extraction Strategy, and Advanced Medical Options for Veterinarians, 访问时间为四月 7, 2026， https://veterinarydentistry.net/feline-chronic-gingivostomatitis-diagnosis-treatment/
Feline Chronic Gingivostomatitis: An Update, 访问时间为四月 7, 2026， https://todaysveterinarynurse.com/dentistry/feline-chronic-gingivostomatitis-an-update/
Effect of tooth extraction on stomatitis in cats: 95 cases (2000-2013). - - VIN, 访问时间为四月 7, 2026， https://www.vin.com/VSPNAOW/Journal.plx?AID=2051455&AOW=1
Viral Coinfections Potentially Associated with Feline Chronic Gingivostomatitis in Cats with Feline Infectious Peritonitis - MDPI, 访问时间为四月 7, 2026， https://www.mdpi.com/1999-4915/17/11/1505
An updated approach to chronic feline gingivitis stomatitis syndrome - Apex Veterinary Specialists, 访问时间为四月 7, 2026， https://apexvetss.com/wp-content/uploads/2023/02/johnston-good20stm20summary-2012.pdf
Epidemiological investigation of feline chronic gingivostomatitis and its relationship with oral microbiota in Xi'an, China - Frontiers, 访问时间为四月 7, 2026， https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2024.1418101/full
Feline Chronic Gingivostomatitis: Clinical Data on Stem Cell Efficacy from Gallant, 访问时间为四月 7, 2026， https://www.latimes.com/veterinarians/health/diagnostics/story/feline-chronic-gingivostomatitis-stem-cell-study-insights
Feline chronic gingivostomatitis: a thorough systematic review of associated factors - PMC, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC12035028/
Management of Chronic Ginggivostomatitis In Local Cats With A History of Recovery From Feline Calici Virus | Journal of Applied Veterinary Science And Technology, 访问时间为四月 7, 2026， https://e-journal.unair.ac.id/JAVEST/article/view/64798
Feline chronic gingivostomatitis current concepts in clinical management - PMC, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC10811996/
Case Report: Xenogeneic mesenchymal stem cell secretome for the treatment of feline chronic gingivostomatitis - Frontiers, 访问时间为四月 7, 2026， https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2025.1603383/full
Proposed guidelines on the management of Feline Chronic Gingivostomatitis (FCGS) syndrome: a consensus statement Consultation, 访问时间为四月 7, 2026， https://www.tierzahnaerzte.de/images/Tierzahnaerzte/Fuer_Tieraerztinnen_und_Tieraerzte/Dezember2021/FCGS_Conscensus_Paper.pdf
Relationship between Feline calicivirus Load, Oral Lesions, and Outcome in Feline Chronic Gingivostomatitis (Caudal Stomatitis): Retrospective Study in 104 Cats - Frontiers, 访问时间为四月 7, 2026， https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2017.00209/full
Feline chronic gingivostomatitis: a thorough systematic review of associated factors, 访问时间为四月 7, 2026， https://pubmed.ncbi.nlm.nih.gov/40231602/
Feline Stomatitis - MSPCA-Angell, 访问时间为四月 7, 2026， https://www.mspca.org/angell_services/feline-stomatitis/
Addressing The Root Of The Problem: How To Navigate Feline Chronic Gingivostomatitis - Texas A&M College of Veterinary Medicine, 访问时间为四月 7, 2026， https://vetmed.tamu.edu/news/pet-talk/feline-chronic-gingivostomatitis-treatment/
Calicivirus in Cats: Everything You Need to Know - Veteris, 访问时间为四月 7, 2026， https://veteris.co.uk/petcare-advice/calicivirus-in-cats
Mesenchymal stromal cell therapy for feline chronic gingivostomatitis: Long term experience, 访问时间为四月 7, 2026， https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2023.1171922/full
Feline Oral Cavity Conditions - Dental Vets, 访问时间为四月 7, 2026， https://www.dentalvets.co.uk/common-cases/feline-oral-cavity-conditions
New guidelines call for earlier diagnosis, intervention in feline dental disease | American Veterinary Medical Association, 访问时间为四月 7, 2026， https://www.avma.org/news/new-guidelines-call-earlier-diagnosis-intervention-feline-dental-disease
Feline Stomatitis - Dental Disease in Cats, 访问时间为四月 7, 2026， https://orvetdentalspecialists.com/feline-stomatitis/
Chronic feline stomatitis? Try extraction, CO2 laser - VetScalpel, 访问时间为四月 7, 2026， https://www.vetscalpel.com/wp-content/uploads/2013/08/52-09-2016_Bellows.pdf
Feline Chronic Stomatitis: Full Mouth Extraction Success in Cats - Tooth.Vet, 访问时间为四月 7, 2026， https://tooth.vet/beneath-the-surface-animal-dentistry-referral-services-case-chronicles/ics-feline
Why Full Mouth Extractions Give Your Cat a New Lease on Life! - Your Pet Dentist, 访问时间为四月 7, 2026， https://yourpetdentist.com/why-full-mouth-extractions-give-your-cat-a-new-and-comfortable-lease-on-life/
NIR Laser Therapy in the Management of Feline Stomatitis - Asalaser, 访问时间为四月 7, 2026， https://www.asalaser.com/sites/default/files/ricerca/documenti/nir_laser_therapy_feline_stomatitis.pdf
Will My Pet be OK After Full Mouth Extractions? | AAD - Advanced Animal Dentistry, 访问时间为四月 7, 2026， https://animaldental.com.au/will-my-pet-be-ok-after-full-mouth-extractions/
Pet Dental Health Cat Disappearing Teeth - Veterinary Medicine at Illinois, 访问时间为四月 7, 2026， https://vetmed.illinois.edu/pet-health-columns/cat-disappearing-teeth-pet-dental-health/
Mesenchymal stromal cell therapy for feline chronic gingivostomatitis: Long term experience, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC10165997/
Feline Stomatitis Study by Our Own Dr. Durso - The Cooke Veterinary Medical Center, 访问时间为四月 7, 2026， https://cookevet.com/feline-stomatitis-study-by-our-own-dr-durso/
Therapeutic Management of Feline Chronic Gingivostomatitis: A Systematic Review of the Literature - PMC, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC4947586/
Assessing the potential efficacy of 830-nanometer low-level laser therapy in cats: Extraoral applications - ResearchGate, 访问时间为四月 7, 2026， https://www.researchgate.net/publication/380723142_Assessing_the_potential_efficacy_of_830-nanometer_low-level_laser_therapy_in_cats_Extraoral_applications
2025 FelineVMA feline oral health and dental care guidelines - PMC, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC12665832/
Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis - PMC, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC7129178/
Clinical field study evaluating the safety and efficacy of allogeneic uterine-derived mesenchymal stem cells for refractory feline chronic gingivostomatitis - PubMed, 访问时间为四月 7, 2026， https://pubmed.ncbi.nlm.nih.gov/40999564/
Molnupiravir–Doxycycline–Meloxicam Paste for Feline ... - VetScripts, 访问时间为四月 7, 2026， https://new.vetscripts.co.za/wp-content/uploads/2025/10/28-Molnupiravir%E2%80%93Doxycycline%E2%80%93Meloxicam-Paste-for-Feline-Gingivostomatitis.pdf
(ID26) Effects of Molnupiravir on Clinical Remission and Calicivirus Shedding in Cats with Chronic Gingivostomatitis - 2025 ACVIM Forum, 访问时间为四月 7, 2026， https://2025acvimforum.eventscribe.net/ajaxcalls/PosterInfo.asp?PosterID=735598
FIP & FCV Research in Cats | Antiviral Studies | MolnuFIP™, 访问时间为四月 7, 2026， https://www.molnufip.com/clinical-studies
Assessing the potential efficacy of 830-nanometer low-level laser therapy in cats: Extraoral applications - PMC, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC11188886/
Laser Therapy Benefits in Veterinary Patients With Dental & Oral Conditions, 访问时间为四月 7, 2026， https://publications.companionanimalhealth.com/benefits-of-photobiomodulation-in-veterinary-patients-with-dental-and-oral-conditions
Adjunctive low-level laser therapy improves gingival inflammatory clinical indices, thermographic findings, and systemic cytokines in cats with American Veterinary Dental College stage 1 to 2 periodontal disease in - AVMA Journals, 访问时间为四月 7, 2026， https://avmajournals.avma.org/view/journals/ajvr/aop/ajvr.25.10.0385/ajvr.25.10.0385.xml
Gingivitis stomatitis complex in cats - Celtic SMR, 访问时间为四月 7, 2026， https://www.celticsmr.co.uk/news/small-animal-news-items/gingivitis-stomatitis-complex-in-cats/
WSAVA Feline Vaccination Guidelines - VIN, 访问时间为四月 7, 2026， https://www.vin.com/apputil/content/defaultadv1.aspx?pId=20539&id=8506325
WSAVA Guidelines for the vaccination of dogs and cats - PMC - NIH, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC7166872/
Calicivirus Infection in Cats - PMC - NIH, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC9145992/
Feline Calicivirus | Cornell University College of Veterinary Medicine, 访问时间为四月 7, 2026， https://www.vet.cornell.edu/departments-centers-and-institutes/baker-institute-animal-health/research-baker-institute/feline-calicivirus
WSAVA Guidelines for the Vaccination of Dogs and Cats - PMC - NIH, 访问时间为四月 7, 2026， https://pmc.ncbi.nlm.nih.gov/articles/PMC7166980/
CORE VACCINES FOR PET CATS NON-CORE VACCINES FOR PET CATS - WSAVA, 访问时间为四月 7, 2026， https://wsava.org/wp-content/uploads/2025/06/Cats-Vaccination-Table.pdf

Causes and Treatment Plans for Stomatitis in Cats